Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Childhood hearing loss ranges from mild to profound. Children with mild hearing loss may have trouble hearing quiet talking while children with profound hearing loss may not have any hearing.
Our Diabetes & Endocrinology research group focuses on the impact of diabetes on the developing brain, mental health and quality of life.
Food allergies in children are on the rise worldwide, with symptoms ranging from mild skin rash to life-threatening anaphylaxis. In food allergy, the immune system incorrectly identifies the specific food as a threat when entering the body. Some food allergy symptoms are mild but severe symptoms
AQUA is one of the world’s largest long-term studies looking at the effects on child development of drinking low or moderate levels of alcohol in pregnancy. Women are told not to drink during pregnancy to protect their babies. But can the occasional glass of wine hurt? And what if a woman has
EARSHOT Study is an international, multicentre prospective cohort study evaluating the risk of hearing loss in children receiving antibiotic treatment. We are improving paediatric care by predicting and preventing aminoglycoside antibiotic associated hearing damage.
We address the major treatable and preventable diseases that affect populations in the Asia-Pacific with a focus on equity and the health professionals and systems which deliver care.
We aim to change the trajectory of global childhood and adult health to reduce the impact of infectious diseases and allergies.
Our group aims to improve the long-term quality of life for children born preterm.
We are developing a fast and accurate bedside test to detect congenital Cytomegolovirus (cCMV) cost effectively in the first weeks of life. We understand that cCMV may be treatable in some cases if detected in the first month of life.
Vaccine research, safety and surveillance, and immunisation education. Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) is a public health partnership initiative of the Victorian Immunisation Program funded by the Department of Health, Victoria.
Page 98 of 100
